• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

XCL1-XCR1轴支持肠道组织驻留和抗肿瘤免疫。

The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity.

作者信息

Ferry Amir, Mempel Kianoosh M, Monell Alexander, Reina-Campos Miguel, Scharping Nicole E, Heeg Maximilian, Takehara Kennidy K, Schokrpur Shiruyeh, Kuo Ning, Saddawi-Konefka Robert, Gutkind J Silvio, Goldrath Ananda W

机构信息

School of Biological Sciences, University of California, San Diego, La Jolla, CA, USA.

La Jolla Institute for Immunology , La Jolla, CA, USA.

出版信息

J Exp Med. 2025 Mar 3;222(2). doi: 10.1084/jem.20240776. Epub 2025 Jan 22.

DOI:10.1084/jem.20240776
PMID:39841133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11753173/
Abstract

Tissue-resident memory T cells (TRM) provide frontline protection against pathogens and emerging malignancies. Tumor-infiltrating lymphocytes (TIL) with TRM features are associated with improved clinical outcomes. However, the cellular interactions that program TRM differentiation and function are not well understood. Using murine genetic models and targeted spatial transcriptomics, we found that the CD8+ T cell-derived chemokine XCL1 is critical for TRM formation and conventional DC1 (cDC1) supported the positioning of intestinal CD8+ T cells during acute viral infection. In tumors, enforced Xcl1 expression by antigen-specific CD8+ T cells promoted intratumoral cDC1 accumulation and T cell persistence, leading to improved overall survival. Notably, analysis of human TIL and TRM revealed conserved expression of XCL1 and XCL2. Thus, we have shown that the XCL1-XCR1 axis plays a non-cell autonomous role in guiding intestinal CD8+ TRM spatial differentiation and tumor control.

摘要

组织驻留记忆T细胞(TRM)为抵御病原体和新出现的恶性肿瘤提供一线保护。具有TRM特征的肿瘤浸润淋巴细胞(TIL)与改善的临床结果相关。然而,调控TRM分化和功能的细胞间相互作用尚不清楚。利用小鼠遗传模型和靶向空间转录组学,我们发现CD8 + T细胞衍生的趋化因子XCL1对TRM形成至关重要,并且传统的1型树突状细胞(cDC1)在急性病毒感染期间支持肠道CD8 + T细胞的定位。在肿瘤中,抗原特异性CD8 + T细胞强制表达Xcl1可促进肿瘤内cDC1积累和T细胞持久性,从而改善总生存期。值得注意的是,对人类TIL和TRM的分析揭示了XCL1和XCL2的保守表达。因此,我们已经表明,XCL1-XCR1轴在指导肠道CD8 + TRM空间分化和肿瘤控制中发挥非细胞自主作用。

相似文献

1
The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity.XCL1-XCR1轴支持肠道组织驻留和抗肿瘤免疫。
J Exp Med. 2025 Mar 3;222(2). doi: 10.1084/jem.20240776. Epub 2025 Jan 22.
2
Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer.负载cDC1特异性趋化因子XCL1的成熟树突状细胞衍生的细胞外囊泡联合化疗诱导的免疫原性细胞死亡用于去势抵抗性前列腺癌的治疗。
Cancer Immunol Immunother. 2025 Jun 18;74(8):242. doi: 10.1007/s00262-025-04070-8.
3
Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironment.增强子驱动的基因调控网络揭示了在肿瘤微环境中控制T细胞适应性和分化的转录因子。
Immunity. 2025 Jul 8;58(7):1725-1741.e9. doi: 10.1016/j.immuni.2025.04.030. Epub 2025 May 26.
4
Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapies.不同的肿瘤驻留记忆T细胞亚群调节对抗程序性死亡蛋白1(anti-PD-1)和抗细胞毒性T淋巴细胞相关蛋白4(anti-CTLA-4)癌症免疫疗法的反应。
Nat Commun. 2025 Jul 1;16(1):5588. doi: 10.1038/s41467-025-60657-w.
5
T-bet deficiency and Hic1 induction override TGF-β-dependency in the formation of CD103 intestine-resident memory CD8 T cells.T-bet 缺陷和 Hic1 诱导可克服 TGF-β 依赖性,从而形成 CD103 肠道驻留记忆 CD8 T 细胞。
Cell Rep. 2024 Jun 25;43(6):114258. doi: 10.1016/j.celrep.2024.114258. Epub 2024 May 22.
6
CRISPR screens unveil nutrient-dependent lysosomal and mitochondrial nodes impacting intestinal tissue-resident memory CD8 T cell formation.CRISPR 筛选揭示了影响肠道组织驻留记忆 CD8 T 细胞形成的营养依赖性溶酶体和线粒体节点。
Immunity. 2024 Nov 12;57(11):2597-2614.e13. doi: 10.1016/j.immuni.2024.09.013. Epub 2024 Oct 14.
7
Acellular Pertussis Vaccines Induce CD8 and CD4 Regulatory T Cells That Suppress Protective Tissue-Resident Memory CD4 T Cells, in Part via IL-10.无细胞百日咳疫苗可诱导CD8和CD4调节性T细胞,这些细胞部分通过白细胞介素-10抑制保护性组织驻留记忆CD4 T细胞。
Eur J Immunol. 2025 Jul;55(7):e51630. doi: 10.1002/eji.202451630.
8
IL-33 Increases the Magnitude of the Tissue-Resident Memory T Cell Response in Intestinal Tissues during Local Infection.白细胞介素-33增强局部感染期间肠道组织中组织驻留记忆T细胞反应的强度。
J Immunol. 2024 Dec 15;213(12):1884-1892. doi: 10.4049/jimmunol.2400323.
9
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.抗 PD-1 治疗的肺癌中 neoantigen 特异性 TIL 的转录程序。
Nature. 2021 Aug;596(7870):126-132. doi: 10.1038/s41586-021-03752-4. Epub 2021 Jul 21.
10
Id2 levels determine the development of effector vs. exhausted tissue-resident memory CD8 T cells during CNS chronic infection.在中枢神经系统慢性感染期间,Id2水平决定效应性与耗竭性组织驻留记忆CD8 T细胞的发育。
Cell Rep. 2025 Jun 24;44(6):115861. doi: 10.1016/j.celrep.2025.115861. Epub 2025 Jun 17.

本文引用的文献

1
Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted.组织驻留记忆性CD8 T细胞的多样性在时空上被印记。
Nature. 2025 Mar;639(8054):483-492. doi: 10.1038/s41586-024-08466-x. Epub 2025 Jan 22.
2
Universal recording of immune cell interactions in vivo.在体实时记录免疫细胞相互作用。
Nature. 2024 Mar;627(8003):399-406. doi: 10.1038/s41586-024-07134-4. Epub 2024 Mar 6.
3
CD8 T cells in the cancer-immunity cycle.肿瘤免疫循环中的 CD8 T 细胞。
Immunity. 2023 Oct 10;56(10):2231-2253. doi: 10.1016/j.immuni.2023.09.005.
4
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.具有细胞毒性潜力的肿瘤驻留 T 细胞与头颈部癌症新辅助抗 PD-1 治疗的反应相关。
Sci Immunol. 2023 Sep 8;8(87):eadf4968. doi: 10.1126/sciimmunol.adf4968.
5
Spatial predictors of immunotherapy response in triple-negative breast cancer.三阴性乳腺癌免疫治疗反应的空间预测因子。
Nature. 2023 Sep;621(7980):868-876. doi: 10.1038/s41586-023-06498-3. Epub 2023 Sep 6.
6
Metabolic programs of T cell tissue residency empower tumour immunity.T 细胞组织驻留的代谢程序赋予了肿瘤免疫能力。
Nature. 2023 Sep;621(7977):179-187. doi: 10.1038/s41586-023-06483-w. Epub 2023 Aug 30.
7
Tumor immunogenicity dictates reliance on TCF1 in CD8 T cells for response to immunotherapy.肿瘤免疫原性决定了 CD8 T 细胞依赖 TCF1 对免疫治疗产生反应。
Cancer Cell. 2023 Sep 11;41(9):1662-1679.e7. doi: 10.1016/j.ccell.2023.08.001. Epub 2023 Aug 24.
8
A distinct stimulatory cDC1 subpopulation amplifies CD8 T cell responses in tumors for protective anti-cancer immunity.一种独特的刺激型 cDC1 亚群在肿瘤中扩增 CD8 T 细胞反应,以产生保护性的抗癌免疫。
Cancer Cell. 2023 Aug 14;41(8):1498-1515.e10. doi: 10.1016/j.ccell.2023.06.008. Epub 2023 Jul 13.
9
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses.肿瘤源性前列腺素 E2 程序性调控 cDC1 功能障碍,从而损害抗肿瘤 T 细胞反应在肿瘤内的协调作用。
Immunity. 2023 Jun 13;56(6):1341-1358.e11. doi: 10.1016/j.immuni.2023.05.011.
10
Localization, tissue biology and T cell state - implications for cancer immunotherapy.定位、组织生物学和 T 细胞状态——对癌症免疫治疗的影响。
Nat Rev Immunol. 2023 Dec;23(12):807-823. doi: 10.1038/s41577-023-00884-8. Epub 2023 May 30.